Atomos Ltd posted a 22.5% revenue increase to $40 million for FY26, returning to profitability with a $0.9 million net profit after tax, buoyed by cost cuts and the strategic acquisition of Flanders Scientific.
- 22.5% revenue growth to $40 million
- Return to profit with $0.9 million net income
- EBITDA improves 131% to $3.7 million
- Fixed costs cut 22.5% following prior restructuring
- Acquisition of Flanders Scientific completed April 2026
Profitability Returns After Prior Year Loss
Atomos Ltd (ASX:AMS) has reversed a $14.6 million loss in FY25 to post a $0.9 million net profit after tax for the year ended 30 June 2026. Revenue climbed 22.5% to $40.0 million, driven by improved product cost outcomes and a 37.2% contribution margin, more than doubling from 16.8% the previous year. EBITDA surged 131% to $3.7 million, marking a clear operational turnaround.
Cost Cuts and Margin Expansion Fuelled Earnings
The Group slashed fixed costs by 22.5% to $12.5 million, with employee benefits, advertising, and legal expenses all materially reduced following a restructuring completed in FY25. This leaner cost base, combined with pricing adjustments related to the US Administration’s now-reversed IEEPA tariffs, helped lift margins despite a second half revenue shortfall attributed to subdued end-consumer demand and delayed product shipments.
Inventory provisions also played a notable role, with a $1.2 million release of obsolescence provisions and $0.5 million from onerous contract provisions boosting the contribution margin by 4.2 percentage points. These releases, alongside a 22.5% revenue increase and a $3.6 million fixed cost reduction, accounted for a significant portion of the EBITDA improvement.
Flanders Scientific Acquisition Adds Strategic Depth
In April 2026, Atomos completed the acquisition of Flanders Scientific, Inc., a recognised brand in professional colour reference monitors. The deal, valued at approximately $2.5 million including cash, shares, and contingent consideration, extends Atomos’s product range into studio and post-production workflows. Flanders contributed $1.8 million in revenue and a minor loss of $13,000 in the final quarter of FY26.
The acquisition also brought $4.6 million in intangible assets, including a supply agreement, trademark, and customer relationships, with corresponding deferred tax liabilities and assets recognised. The business combination is provisional and subject to adjustment within the next twelve months.
Cash Flow and Balance Sheet Highlights
Despite the return to profit, Atomos reported net cash outflows from operating activities of $5.0 million, though this was an improvement on the prior year’s $13.3 million outflow. Borrowings increased to $20.9 million, reflecting funding for the acquisition and working capital needs. Net tangible assets remain negative at 0.5 cents per share, though the Company raised $8.0 million in equity during the year, increasing the share count to 1.49 billion.
The Group’s Annual General Meeting will be held online on 19 November 2026, with no dividends declared or proposed, consistent with prior years.
Second Half Performance and Market Conditions
Second half revenue fell 31.3% to $16.3 million compared to the first half, reflecting softer demand and delayed shipments, including the late launch of the Sumo PRO 19. However, the contribution margin improved to 40.8% in H2 from 34.7% in H1 due to the reversal of US tariff costs, resulting in a steady EBITDA of $1.8 million in the second half.
This nuanced performance underscores the impact of external macroeconomic factors and timing on Atomos’s sales cycle, despite underlying margin strength and operational discipline.
Bottom Line?
Atomos’s FY26 results mark a significant recovery but the ongoing cash burn and negative net tangible assets highlight the need for sustained revenue growth and cost control to secure long-term stability.
Questions in the middle?
- Can Atomos sustain margin gains amid volatile global demand and supply chain pressures?
- How will the integration of Flanders Scientific influence future revenue and profitability?
- What impact will the pending final audit and going concern uncertainty have on investor confidence?